ENTOS
LIVE

Serial Number

90894329

Owner

Entos, Inc.

Attorney

Theodore R. Remaklus

First Use Date

Oct 3, 2013

Filing Date

Aug 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ENTOS Trademark

Serial Number: 90894329 • Registration: 7151783

ENTOS is a trademark filed by Entos, Inc. on August 20, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Entos, Inc. (4 trademarks)

Los Angeles, CA 90027

Entity Type: 03

ENTOS PHARMACEUTICALS INC. (9 trademarks)

10230 JASPER AVENUE, UNIT 4550
EDMONTON, AB T5J4P6 , CA

Entity Type: 03

Trademark Details

Filing Date

August 20, 2021

Registration Date

August 29, 2023

First Use Anywhere

October 3, 2013

First Use in Commerce

October 3, 2013

Published for Opposition

October 25, 2022

Goods & Services

research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (saas) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 4, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2025 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 1, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 1, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 1, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 1, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 1, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 1, 2023 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 30, 2023 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 29, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 29, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 27, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 26, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 25, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 24, 2023 AITU
USE AMENDMENT FILED
Jun 30, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 30, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 13, 2023 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 4, 2023 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 27, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 23, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 23, 2022 CNRT
ASSIGNED TO EXAMINER
May 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 7, 2021 NWOS
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 8, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 8, 2021 COAR
NEW APPLICATION ENTERED
Aug 24, 2021 NWAP